Both in null
Lycia Therapeutics vs State Street SPDR S&P 500 ETF Trust
| Metric | LYCA | SPY |
|---|---|---|
| Price | $26.40 | $755.72 |
| Market cap | $1.38B | $801.96B |
| Today | −4.80% | −1.77% |
| 1 month | — | −1.1% |
| 6 months | — | +4.9% |
| Year to date | — | +10.8% |
| 1 year | — | +9.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | 1.00% |
| Volatility (60d) | — | 9.9% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).